Ras-ERK1/2 Signaling Promotes The Development Of Osteosarcoma By Regulating H2BK12ac Through CBP

References

• Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program. Cancer. 2009;115(7):1531–1543. doi:10.1002/cncr.2412119197972
   PubMed Web of Science ®Google Scholar
• Jimenez C, Yang Y, Kim HW, et al. Primary hyperparathyroidism and osteosarcoma: examination of a large cohort identifies three cases of fibroblastic osteosarcoma. J Bone Miner Res. 2005;20(9):1562–1568. doi:10.1359/JBMR.05050716059628
   PubMed Web of Science ®Google Scholar
• Ma K, Huang MY, Guo YX, Hu GQ. Matrine-induced autophagy counteracts cell apoptosis via the ERK signaling pathway in osteosarcoma cells. Oncol Lett. 2016;12(3):1854–1860. doi:10.3892/ol.2016.484827588132
   PubMed Web of Science ®Google Scholar
• Yu Y, Luk F, Yang JL, Walsh WR. Ras/Raf/MEK/ERK pathway is associated with lung metastasis of osteosarcoma in an orthotopic mouse model. Anticancer Res. 2011;31(4):1147–1152.21508358
   PubMed Web of Science ®Google Scholar
• Yang R, Piperdi S, Gorlick R. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma. Clin Cancer Res. 2008;14(20):6396–6404. doi:10.1158/1078-0432.CCR-07-511318927278
   PubMed Web of Science ®Google Scholar
• Zhang W, Lee JC, Kumar S, Gowen M. ERK pathway mediates the activation of Cdk2 in IGF-1-induced proliferation of human osteosarcoma MG-63 cells. J Bone Miner Res. 1999;14(4):528–535. doi:10.1359/jbmr.1999.14.4.52810234573
   PubMed Web of Science ®Google Scholar
• Poudel B, Kim DK, Ki HH, Kwon YB, Lee YM, Kim DK. Downregulation of ERK signaling impairs U2OS osteosarcoma cell migration in collagen matrix by suppressing MMP9 production. Oncol Lett. 2014;7(1):215–218. doi:10.3892/ol.2013.165524348851
   PubMed Web of Science ®Google Scholar
• Chaudhary SC, Siddiqui MS, Athar M, Alam MS. Geraniol inhibits murine skin tumorigenesis by modulating COX-2 expression, Ras-ERK1/2 signaling pathway and apoptosis. J Appl Toxicol. 2013;33(8):828–837. doi:10.1002/jat.273922760862
   PubMed Web of Science ®Google Scholar
• Buhrman G, Kumar VSS, Cirit M, Haugh JM, Mattos C. Allosteric modulation of Ras-GTP is linked to signal transduction through RAF kinase. J Biol Chem. 2011;286(5):3323. doi:10.1074/jbc.M110.19385421098031
   PubMed Web of Science ®Google Scholar
• Zheng ZY, Cheng C, Fu XR, Zhou S, Chang EC. Abstract 5074: identification of Ras compartment-specific interacting proteins. Cancer Res. 2011;70(8 Supplement):5074.
   Google Scholar
• Liu RT, Hou CY, You HL, et al. Selective occurrence of Ras mutations in benign and malignant thyroid follicular neoplasms in Taiwan. Thyroid. 2004;14(8):616–621. doi:10.1089/105072504169288215320975
   PubMed Web of Science ®Google Scholar
• Demunter A, Ahmadian MR, Libbrecht L, et al. A novel N-Ras mutation in malignant melanoma is associated with excellent prognosis. Cancer Res. 2001;61(12):4916–4922.11406571
   PubMed Web of Science ®Google Scholar
• Neilsen BK, Frodyma DE, Lewis RE, Fisher KW. KSR as a therapeutic target for Ras-dependent cancers. Expert Opin Ther Targets. 2017;21(5):499–509. doi:10.1080/14728222.2017.131132528333549
   PubMed Web of Science ®Google Scholar
• Chen M, Lin H, Zhao H. Change point analysis of histone modification reveals epigenetic blocks linking to physical domains. Ann Appl Stat. 2016;10(1):506–526. doi:10.1214/16-AOAS90527231496
   PubMed Web of Science ®Google Scholar
• Torres-Padilla ME, Parfitt DE, Kouzarides T, Zernicka-Goetz M. Histone arginine methylation regulates pluripotency in the early mouse embryo. Nature. 2007;445(7124):214–218. doi:10.1038/nature0545817215844
   PubMed Web of Science ®Google Scholar
• Li D, Shi J, Du Y, et al. Profiling analysis of histone modifications and gene expression in Lewis lung carcinoma murine cells resistant to anti-VEGF treatment. PLoS One. 2016;11(6):e0158214. doi:10.1371/journal.pone.015821427362259
   PubMed Web of Science ®Google Scholar
• Chen H, Ruiz PD, Novikov L, Casill AD, Park JW, Gamble MJ. MacroH2A1.1 and PARP-1 cooperate to regulate transcription by promoting CBP-mediated H2B acetylation. Nat Struct Mol Biol. 2014;21(11):981–989. doi:10.1038/nsmb.290325306110
   PubMed Web of Science ®Google Scholar
• Imwong M, Dondorp AM, Nosten F, et al. Exploring the contribution of candidate genes to artemisinin resistance in plasmodium falciparum. Antimicrob Agents Chemother. 2010;54(7):2886–2892. doi:10.1128/AAC.00032-1020421395
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang D-L, Chen S, Zhao L, Sun F-L. Oncogene Ras/Phosphatidylinositol 3-kinase (PI3K) signaling targets histone H3 acetylation at lysine K56. J Biol Chem. 2012;287(49):41469–41480.22982396
   PubMed Web of Science ®Google Scholar
• Wu CE, Esfandiari A, Ho YH, et al. Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma. Br J Cancer. 2018;118(4):495–508. doi:10.1038/bjc.2017.43329235570
   PubMed Web of Science ®Google Scholar
• Wang Y, Guo W, Shen D, et al. Surgical treatment of primary osteosarcoma of the sacrum: a case series of 26 patients. Spine. 2017;42(16):1207–1213. doi:10.1097/BRS.000000000000204327997504
   PubMed Web of Science ®Google Scholar
• Anderson L, Gomes MR, daSilva LF, et al. Histone deacetylase inhibition modulates histone acetylation at gene promoter regions and affects genome-wide gene transcription in schistosoma mansoni. PLoS Negl Trop Dis. 2017;11(4):e0005539. doi:10.1371/journal.pntd.000553928406899
   PubMed Web of Science ®Google Scholar
• Yen CY, Huang HW, Shu CW, et al. DNA methylation, histone acetylation and methylation of epigenetic modifications as a therapeutic approach for cancers. Cancer Lett. 2016;373(2):185–192. doi:10.1016/j.canlet.2016.01.03626808576
   PubMed Web of Science ®Google Scholar
• Nouzova M, Holtan N, Oshiro MM, et al. Epigenomic changes during leukemia cell differentiation: analysis of histone acetylation and cytosine methylation using CpG island microarrays. J Pharmacol Exp Ther. 2004;311(3):968–981. doi:10.1124/jpet.104.07248815302897
   PubMed Web of Science ®Google Scholar
• Ashktorab H, Belgrave K, Hosseinkhah F, et al. Global histone H4 acetylation and HDAC2 expression in colon adenoma and carcinoma. Dig Dis Sci. 2009;54(10):2109–2117. doi:10.1007/s10620-008-0601-719057998
   PubMed Web of Science ®Google Scholar
• van Bavel CC, Dieker J, Muller S, et al. Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies. Mol Immunol. 2009;47(2–3):511–516. doi:10.1016/j.molimm.2009.08.00919747733
   PubMed Web of Science ®Google Scholar
• Barlesi F, Giaccone G, Gallegos-Ruiz MI, et al. Global histone modifications predict prognosis of resected non small-cell lung cancer. J Clin Oncol. 2007;25(28):4358–4364. doi:10.1200/JCO.2007.11.259917906200
   PubMed Web of Science ®Google Scholar
• Cai RL, Yan-Neale Y, Cueto MA, Xu H, Cohen D. HDAC1, a histone deacetylase, forms a complex with Hus1 and Rad9, two G2/M checkpoint Rad proteins. J Biol Chem. 2000;275(36):27909–27916. doi:10.1074/jbc.M00016820010846170
   PubMed Web of Science ®Google Scholar
• Hayashi A, Horiuchi A, Kikuchi N, et al. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin. Int J Cancer. 2010;127(6):1332–1346. doi:10.1002/ijc.2515120049841
   PubMed Web of Science ®Google Scholar
• Zhang L, Bu L, Hu J, et al. HDAC1 knockdown inhibits invasion and induces apoptosis in non-small cell lung cancer cells. Biol Chem. 2018;399(6):603–610. doi:10.1515/hsz-2017-030629537214
   PubMed Web of Science ®Google Scholar
• Burdelski C, Ruge OM, Melling N, et al. HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer. Exp Mol Pathol. 2015;98(3):419–426. doi:10.1016/j.yexmp.2015.03.02425794974
   PubMed Web of Science ®Google Scholar
• Tang Z, Ding S, Huang H, et al. HDAC1 triggers the proliferation and migration of breast cancer cells via upregulation of interleukin-8. Biol Chem. 2017;398(12):1347–1356. doi:10.1515/hsz-2017-015528779562
   PubMed Web of Science ®Google Scholar
• Kar S. p300/CBP proteins: a HAT trick to determine cell fate. Prajnan O Sadhona. 2015;143.
   Google Scholar
• Philip P, Boija A, Vaid R, et al. CBP binding outside of promoters and enhancers in drosophila melanogaster. Epigenetics Chromatin. 2015;8:48. doi:10.1186/s13072-015-0042-426604986
   PubMed Web of Science ®Google Scholar
• Inagaki Y, Shiraki K, Sugimoto K, et al. Epigenetic regulation of proliferation and invasion in hepatocellular carcinoma cells by CBP/p300 histone acetyltransferase activity. Int J Oncol. 2016;48(2):533–540. doi:10.3892/ijo.2015.328826676548
   PubMed Web of Science ®Google Scholar
• Abell AN, Jordan NV, Huang W, et al. MAP3K4/CBP-regulated H2B acetylation controls epithelial-mesenchymal transition in trophoblast stem cells. Cell Stem Cell. 2011;8(5):525–537. doi:10.1016/j.stem.2011.03.00821549327
   PubMed Web of Science ®Google Scholar
• Bouska A, Eischen CM. Mdm2 affects genome stability independent of p53. Cancer Res. 2009;69(5):1697–1701. doi:10.1158/0008-5472.CAN-08-373219244108
   PubMed Web of Science ®Google Scholar
• Minsky N, Oren M. The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression. Mol Cell. 2004;16(4):631–639. doi:10.1016/j.molcel.2004.10.01615546622
   PubMed Web of Science ®Google Scholar